期刊文献+

217例噬血细胞性淋巴组织细胞增生症患儿的临床及实验室检查特点分析 被引量:22

Analysis of clinical and laboratory features of 217 pediatric hemophagocytic lymphohistiocytosis
原文传递
导出
摘要 目的 探讨我国儿童噬血细胞性淋巴组织细胞增生症(HLH)的临床及实验室检查特点.方法 回顾性分析217例HLH患儿的临床及实验室检查资料.结果 217例患儿中男女比例为1.11∶1,中位发病年龄为3岁5个月(6个月~16岁9个月),发病高峰年龄为1~5岁(占61.3%).感染相关HLH最多见(占77%,其中92.2%为EB病毒感染),其余为肿瘤相关HLH、自身免疫性疾病相关HLH等.临床以持续高热(100.0%)、肝脏肿大(92.6%)、脾脏肿大(88.4%)为突出表现,超过半数患儿有中枢神经系统及呼吸系统受累表现.实验室检查结果显示铁蛋白升高最为显著(98.0%),其次为骨髓噬血现象(90.7%)及凝血功能障碍(76.5%);所有患儿均有不同程度的肝功能损害;外周血淋巴细胞分类异常常见.结论 HLH是一组异质性疾病,病因及临床表现多样;HLH-2004诊断方案对于诊断HLH有其理论基础及临床可操作性;肝功能损害相关指标、外周血淋巴细胞分类、中枢神经系统和呼吸系统受累表现对HLH的诊断具有参考价值. Objective To investigate the incidence,clinical symptoms,signs and laboratory features of childhood hemophagocytic lymphohistiocytosis (HLH) in China.Methods A retrospective study was performed on 217 pediatric patients with HLH who were admitted to Children' s Hospital of Chongqing Medical University from January 2006 to April 2013.All patients' medical records were reviewed and analyzed.Results The Male to female ratio was 1.11 ∶ 1.The median onset age was 3 years and 5 months old (range of 6 months old to 16 years and 9 months old),and the age of onset peaked between 1-5 years old (61.3%).The most common causes of HLH was infection,especially Epstein-Barr virus-associated HLH (71.0%).Other causes included malignant hemophagocytic syndrome (MAHS),macrophage activation syndrome (MAS) and so on.The outstanding clinical manifestations including persistent fever (100.0%),hepatomegaly (92.6%),splenomegaly (88.4%),and more than half of cases with central nervous system involvement and pulmonary manifestations.Laboratory data indicated that the most prominent abnormality was elevated ferritin (98.0%),and the others were hemophagocytosis in bone marrow (90.7%) and coagulation abnormalities (76.5%).Abnormal lymphocytes classification is very common in HLH.Conclusions HLH is a heterogeneous disease,with a variety of the etiology and clinical manifestations.HLH-2004 diagnostic protocol had theoretical basis and clinical operability.The hepatitis damages related indicators,lymphocytes classification,central nervous system involvement and pulmonary performance can be used as reference value for HLH diagnosis.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2014年第7期628-632,共5页 Chinese Journal of Hematology
关键词 淋巴组织细胞增多症 嗜血细胞性 儿童 回顾性研究 HLH-2004方案 Lymphohistiocytosis, hemophagocytic Children Retrospective study HLH-2004 protocol
  • 相关文献

参考文献16

  • 1Jordan MB, Allen CE, Weitzman S, et al. How I treat hemo- phagocytic lymphohistiocytosis [J]. Blood, 2011, 118 (15): 4041-4052.
  • 2Henter JI, Home A, Aric6 M, et al. Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J]. Pediatr Blood Cancer, 2007, 48(2): 124-131.
  • 3Asano T, Kogawa K, Morimoto A, et al. Hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplan-tation in children: a nationwide survey in Japan [J]. Pediatr Blood Cancer, 2012, 59( 1 ): 110-114.
  • 4Lee WI, Chen SH, Hung IJ, et al. Clinical aspects, immunologic assessment, and genetic analysis in Taiwan Residents children with hemophagocytic lymphohistiocytosis [J]. Pediatr Infect Dis J, 2009, 28(1): 30-34.
  • 5Qiang Q, Zhengde X, Chunyan L, et al. Killer cell immunoglobu- lin-like receptor gene polymorphisms predispose susceptibility to Epstein-Barr virus associated hemophagocytic lymphohistio- cytosis in Chinese children [J]. Microbiol Immunol, 2012, 56 (6): 378-384.
  • 6Hatta K, Morimoto A, Ishii E, et al. Association of transforming growth factor-betal gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases [J]. Haematolo- gica, 2007, 92( 11 ): 1470-1474.
  • 7Chang YH, Lee DS, Jo HS, et al. Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population [ J ]. Cytokine, 2006, 36 ( 1-2 ): 45-50.
  • 8肖莉,宪莹,戴碧涛,苏庸春,肖剑文,郑启城,赵晓东,于洁.HLH-2004方案治疗83例EB病毒相关噬血淋巴组织细胞增生症患儿疗效分析[J].中华血液学杂志,2011,32(10):668-672. 被引量:24
  • 9Allen CE, Yu X, Kozinetz CA, et al. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis [J]. Pediatr Blood Cancer, 2008, 50(6): 1227-1235.
  • 10Gupta A, Tyrrell P, Valani R, et al. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohis- tiocytosis[ J]. Pediatr Blood Cancer, 2008, 51 (3): 402-404.

二级参考文献12

共引文献115

同被引文献123

  • 1Sumegi J, Huang D, Lanyi A, et al. Correlation of mutations of the SH2DI A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease [J]. Blood, 2000, 96(9): 3118-3125.
  • 2Yang X, Miyawaki T, Kanegme H, et al. SAP and xIAP deficiency in hemophagocytic lymphohistiocytosis [ J ]. Pediatr Int, 2012, 54 (4) : 447-454. DOI:10. llll/j. 1442-200X. 2012. 03683. x.
  • 3Pachlopnik Schmid J, Canioni D, Moshous D, et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency)versus type 2 ( XLP-2/XIAP deficiency ) [ J ]. Blood, 2011, 117 ( 5 ) : 1522-1529. DOI : 10. 1182/blood-2010-07-298372.
  • 4Chuaug HC, Lay JD, Hsieh WC, et al. Epstein-Barr virus LMPI inhibits the expression of SAP gene and upregulates Thl cytokines in the pathogenesis of hemophagocytic syndrome [ J ] . Blood, 2005, 106 ( 9 ) : 3090-3696. DOI : 10. 1182/blood-2005434-1406.
  • 5Seemayer TA, Gross TG, Egeler RM, et al. X-linked lymphoproliferative disease: twenty-five years after the discovery [J] . Pediatr Res, 1995, 38 (4) : 471-478. DOI: 10. 1203/ 00006450-199510000-00001.
  • 6Yang X, Kanegane H, Nishida N, et al. Clinical and genetic characteristics of XIAP deficiency in Japan[ J]. J Clin Immunol, 2012, 32(3) : 411-420. DOI:I0. 1007/s10875-011-9638-z.
  • 7Booth C, Gilmour KC, Veys P, et al. X -linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a muhicenter study on the manifestations, management and outcome of the disease [J] . Blood, 2011, 117 (10): 5352. DOI: 10. 1182/blood-2010-06-284935.
  • 8Henter JI, Home A, Aric6 M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J ]. Pediatr Blood Cancer, 2007, 48 (2) : 124-131. DOI: 10. 1002/ pbc. 21039.
  • 9Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene [ J ]. Nat Genet, 1998, 20(2) : 129-135.
  • 10Kanegane H, Yang X, Zhao M, et al. Clinical features and outcome of X-linkod lymphoproliferative syndrome type 1 (SAP deficiency ) in Japan identified by the combination of flow cytometric assay and genetic analysis [ J ]. Pediatr Allergy Immunol, 2012, 23 ( 5 ) : 488-493. DOI: 10. llll/j. 1399- 3038. 2012. 01282. x.

引证文献22

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部